GlassScriptPhysician profile
Taras Lysyy
NPI 1336984244
$4,926.31
in general payments reported to CMS, 2019-2025
9 companies · $4,502 in 2025
The $4,502 reported for 2025 was more than what 81% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $425 · 2025: $4,502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,147 · Travel and Lodging: $1,672 · Education: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,146.83 |
| Travel and Lodging | $1,671.79 |
| Education | $107.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $2,170.15 | 2025 | Gore Tag Conformable Thoracic Endoprosthesis |
| Atricure, INC. | $1,119.20 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System, Atriclip Laa Exclusion System |
| Abiomed | $507.51 | 2024-2025 | Impella |
| Edwards Lifesciences Corporation | $374.04 | 2025 | Konect Resilia |
| Medtronic, INC. | $328.59 | 2025 | Freestyle, Avalus |
| Arthrex, INC. | $174.76 | 2025 | |
| Zimmer Biomet Holdings, INC. | $113.32 | 2025 | Sternalock 360 System, Sternalock |
| Medical Device Business Services, INC. | $107.69 | 2024 | |
| Briohealth Solutions, INC. | $31.05 | 2025 | Briovad |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taras Lysyy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.